Article
Polycyclic Peptide Therapeutics
25 Jan 2013
Abstract excerpt
Owing to their excellent binding properties, high stability, and low off-target toxicity, polycyclic peptides are an attractive molecule format for the development of therapeutics. Currently, only a handful of polycyclic peptides are used in the clinic; examples include the antibiotic vancomycin, the anticancer drugs actinomycin D and romidepsin, and the analgesic agent ziconotide. All clinically used polycyclic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
